258 related articles for article (PubMed ID: 33691199)
21. Nitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axle.
Mao H; Du Y; Zhang Z; Cao B; Zhao J; Zhou H; Mao X
Anticancer Drugs; 2017 Apr; 28(4):376-383. PubMed ID: 28301380
[TBL] [Abstract][Full Text] [Related]
22. CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.
Cao Y; Li X; Kong S; Shang S; Qi Y
J Cell Mol Med; 2020 May; 24(9):5135-5145. PubMed ID: 32277580
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
24. Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma.
Cui X; Lin Z; Chen Y; Mao X; Ni W; Liu J; Zhou H; Shan X; Chen L; Lv J; Shen Z; Duan C; Hu B; Ni R
Mol Cell Biochem; 2016 Oct; 421(1-2):127-37. PubMed ID: 27573002
[TBL] [Abstract][Full Text] [Related]
25. Roles of TRIM32 in Corneal Epithelial Cells After Infection with Herpes Simplex Virus.
Cui H; Liu Y; Huang Y
Cell Physiol Biochem; 2017; 43(2):801-811. PubMed ID: 28954259
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
27. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
[TBL] [Abstract][Full Text] [Related]
28. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
29. TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.
Borlepawar A; Rangrez AY; Bernt A; Christen L; Sossalla S; Frank D; Frey N
J Biol Chem; 2017 Jun; 292(24):10180-10196. PubMed ID: 28465353
[TBL] [Abstract][Full Text] [Related]
30. PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.
Higuchi F; Fink AL; Kiyokawa J; Miller JJ; Koerner MVA; Cahill DP; Wakimoto H
Mol Cancer Ther; 2018 Dec; 17(12):2551-2563. PubMed ID: 30217967
[TBL] [Abstract][Full Text] [Related]
31. LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma.
Chen WL; Chen HJ; Hou GQ; Zhang XH; Ge JW
Aging (Albany NY); 2019 Aug; 11(16):6053-6068. PubMed ID: 31469661
[TBL] [Abstract][Full Text] [Related]
32. MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.
Kong S; Cao Y; Li X; Li Z; Xin Y; Meng Y
J Cell Mol Med; 2020 Apr; 24(8):4677-4686. PubMed ID: 32181582
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
Qin Y; Cui H; Zhang H
Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
[TBL] [Abstract][Full Text] [Related]
34. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
35. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2.
Kano S; Miyajima N; Fukuda S; Hatakeyama S
Cancer Res; 2008 Jul; 68(14):5572-80. PubMed ID: 18632609
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of TRIM32 Protects Hippocampal Neurons from Oxygen-Glucose Deprivation-Induced Injury.
Wei L; Zhang JS; Ji SF; Xu H; Zhao ZH; Zhang L; Pang L; Zhang JF; Yang PB; Ma H
Neurochem Res; 2019 Sep; 44(9):2182-2189. PubMed ID: 31410708
[TBL] [Abstract][Full Text] [Related]
37. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
Xu JX; Yang Y; Zhang X; Luan XP
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
[TBL] [Abstract][Full Text] [Related]
39. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
Wu J; Li L; Jiang G; Zhan H; Wang N
Int J Oncol; 2016 Dec; 49(6):2471-2479. PubMed ID: 27748795
[TBL] [Abstract][Full Text] [Related]
40. Upregulated Expression of TRIM32 Is Involved in Schwann Cell Differentiation, Migration and Neurite Outgrowth After Sciatic Nerve Crush.
Liu Y; Wu W; Yang H; Zhou Z; Zhu X; Sun C; Liu Y; Yu Z; Chen Y; Wang Y
Neurochem Res; 2017 Apr; 42(4):1084-1095. PubMed ID: 28025799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
